MENU
JUN 10, 2016 8:00 AM PDT

Lupus Anticoagulant (LA): Choosing the Right Testing Strategy for Your Laboratory

Sponsored by: Diagnostica Stago, Inc.
Speaker
  • Associate Professor of Pathology at the Cedars Sinai Medical Center (CSMC) and University of California Los Angeles Hospital
    Biography
      Oksana Volod, MD is Associate Professor of Pathology at the Cedars Sinai Medical Center (CSMC) and University of California Los Angeles Hospital in Los Angeles, CA. She is responsible for the coagulation laboratory and works extensively across multiple departments to ensure best patient testing practices. Her clinical research interests include viscoelastic test utilization for personalized treatment of complex coagulopathies and development of optimal anticoagulation strategies for patients on mechanical circulatory support devices (MCS). In addition, she is a member of the Coagulation Resource Committee of the College of American Pathologists (CAP). Prior to her current position, she performed her residency in Anatomic and Clinical Pathology, along with a fellowship in hematopathology and coagulation at CSMC. She was also a visiting fellow in coagulation at the Royal Free Hospital in London, UK and previously earned her MD at the Uzhgorod State University in Ukraine.

    Abstract

    Lupus anticoagulants are markers of prothrombotic potential which may be indicative of underlying antiphospholipid syndrome (aPS) requiring treatment with ongoing anticoagulants.  The purpose of this educational program is to update healthcare professionals regarding advancements in Lupus Anticoagulant (LA) testing. Current LA diagnostic guidelines, clinical evidence regarding LA significance, assay selection, and anticoagulant drugs interfering with LA testing will be discussed, along with clinical cases of high interest.

    • Describe role of Lupus Anticoagulant (LA) in Antiphospholipid Syndrome (APS).
    • Define current ISTH and CLSI Guidelines, identify tests, and define patient selection for appropriate LA work up.
    • Recognize medications that may cause false positive LA results.
    • Evaluate the right testing strategy for LA testing.
    • Correlate LA and APS to specific clinical cases.

     

     

    P.A.C.E. ® Credits are no longer available for this webinar.


    Show Resources
    You May Also Like
    FEB 24, 2021 10:00 AM PST
    C.E. CREDITS
    FEB 24, 2021 10:00 AM PST
    DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    DEC 03, 2020 4:30 PM PST
    C.E. CREDITS
    DEC 03, 2020 4:30 PM PST
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    JAN 21, 2021 8:00 AM PST
    JAN 21, 2021 8:00 AM PST
    Date: January 21, 2021 Time: 8:00am (PST), 11:00am (EST) Today, critical reagent characterization is a key component in the overall workflow to establish robust ligand binding assays (e.g.,...
    APR 21, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    APR 21, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
    NOV 05, 2020 7:00 AM PST
    C.E. CREDITS
    NOV 05, 2020 7:00 AM PST
    DATE: Date needed, 2020 TIME: Time needed Exosomes are a population of naturally occurring mobile, membrane-limited, 30 – 100 nm in diameter, extracellular vesicles containing a large...
    Loading Comments...
    Show Resources
    Attendees
    • See more